Please Wait

Applying Filters...

Looking for Pharmaceutical Excipients offered by Evonik? Find Carbamazepine to address your drug delivery challenges on PharmaCompass.

Carbamazepine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 22 USDMF, 17 CEP/COS, 7 JDMF, 8 EU WC, 10 KDMF, 20 NDC API, 30 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

289 FDF Dossiers, 91 FDA Orange Book, 91 Europe, 16 Canada, 17 Australia, 16 South Africa, 58 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG, TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 200MG, TABLET, EXTENDED RELEASE;ORAL - 400MG, SOLUTION;INTRAVENOUS - 200MG/20ML (10MG/ML), CAPSULE, EXTENDED RELEASE;ORAL - 100MG, CAPSULE, EXTENDED RELEASE;ORAL - 200MG, CAPSULE, EXTENDED RELEASE;ORAL - 300MG

RELATED EXCIPIENT COMPANIES

2 Evonik, 4 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 10 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 31 BASF, 16 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 31 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 10 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

91 Fillers, Diluents & Binders, 64 Coating Systems & Additives, 43 Controlled & Modified Release, 42 Direct Compression, 34 Thickeners and Stabilizers, 30 Disintegrants & Superdisintegrants, 30 Granulation, 27 Taste Masking, 24 Film Formers & Plasticizers, 24 Solubilizers, 21 Parenteral, 20 Topical, 19 Lubricants & Glidants, 17 Co-Processed Excipients, 16 Chewable & Orodispersible Aids, 12 Emulsifying Agents, 9 Empty Capsules, 7 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 4 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 1 Dry Powder Inhalation, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 35 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 67 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

29 APIs, 15 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 15 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Carbamazepine

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Evonik

filter Capability Reset all filters

filter Country Reset all filters

01

Evonik

Germany

Bio-Europe 2024

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 100-55

Application : Controlled & Modified Release, Solubilizers

Excipient Details : EUDRAGIT® L 100-55 polymer is used in delayed, sustained-release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Capsule, Granule / Pellet, Tablet

Category : Controlled & Modified Release, Solubilizers

Brand : EUDRAGIT® L 100-55

Applications : EUDRAGIT® L 100-55 polymer is used in delayed, sustained-release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55

Grade : Oral

EUDRAGIT® L 100-55

Excipients Web Link

Digital Content

02

Evonik

Germany

Bio-Europe 2024

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® RL 100

Application : Controlled & Modified Release, Solubilizers

Excipient Details : EUDRAGIT® RL, an insoluble, highly permeable polymer used in combination with EUDRAGIT® RS in customized release drugs such as tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Other grades- EUDRAGIT® RL 12,5, EUDRAGIT® RL 30 D, EUDRAGIT® RL PO

Ingredient(s) : Ammonia Methacrylate Copolymer Type A

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ammonia Methacrylate Copolymer Type A

Dosage Form : Capsule, Tablet

Category : Controlled & Modified Release, Solubilizers

Brand : EUDRAGIT® RL 100

Applications : EUDRAGIT® RL, an insoluble, highly permeable polymer used in combination with EUDRAGIT® RS in customized release drugs such as tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Other grades- EUDRAGIT® RL 12,5, EUDRAGIT® RL 30 D, EUDRAGIT® RL PO

Grade : Oral

EUDRAGIT® RL 100

Excipients Web Link

Digital Content